Simulations of mutant p53 DNA binding domains reveal a novel druggable pocket

Mohan R Pradhan1,2, Jia Wei Siau3, Srinivasaraghavan Kannan1

  • 1Bioinformatics Institute, A*STAR (Agency for Science, Technology and Research), 30 Biopolis Street, #07-01 Matrix, Singapore 138671.

Nucleic Acids Research
|January 17, 2019
PubMed

Insights

Mutations in the p53 DNA binding domain (DBD) can cause unfolding and aggregation. Researchers used simulations to find a new druggable pocket in the p53 DBD, offering potential therapeutic targets.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Computational Biology

Background:

  • The p53 tumor suppressor's DNA binding domain (DBD) is frequently mutated in cancer.
  • Certain mutations destabilize the DBD, leading to unfolding, aggregation, and associated pathologies.

Purpose of the Study:

  • To investigate the dynamics of wild-type (WT) and mutant p53 DBDs using molecular dynamics (MD) simulations.
  • To identify structural changes that initiate DBD unfolding and explore potential therapeutic inhibition strategies.

Main Methods:

  • Extensive all-atom explicit solvent molecular dynamics (MD) simulations.
  • Computational screening of FDA-approved drugs against identified pockets.

Main Results:

  • MD simulations revealed differential conformational sampling in the S6-S7 turn region between WT and mutant p53 DBDs.
  • A novel, druggable pocket was identified in the destabilized mutant DBDs.
  • Computational screening identified potential drug candidates for this pocket.

Conclusions:

  • Mutations in the p53 DBD can trigger unfolding via destabilization of a contiguous turn region.
  • The identified druggable pocket presents a promising target for developing inhibitors against oncogenic p53 mutants.

Related Concept Videos

Conservation of Protein Domains Over Different Proteins02:26

Conservation of Protein Domains Over Different Proteins

Protein domains are small structurally independent units that are part of a single amino acid chain.  Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
14.4K
Single-Strand DNA Binding Proteins01:03

Single-Strand DNA Binding Proteins

For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
16.7K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.2K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.0K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.3K